Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1147005

Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients


Gazda, Jakub; Drazilova, Sylvia; Janicko, Martin; Grgurevic, Ivica; Filipec Kanizaj, Tajana; Koller, Tomas; Bodorovska, Beatrica; Bozin, Tonci; Mijic, Maja; Rob, Zrinka et al.
Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients // Journal of Personalized Medicine, 11 (2021), 6; 495-495 doi:10.3390/jpm11060495 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1147005 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients

Autori
Gazda, Jakub ; Drazilova, Sylvia ; Janicko, Martin ; Grgurevic, Ivica ; Filipec Kanizaj, Tajana ; Koller, Tomas ; Bodorovska, Beatrica ; Bozin, Tonci ; Mijic, Maja ; Rob, Zrinka ; Mikolasevic, Ivana ; Madir, Anita ; Kucinsky, Branislav ; Jarcuska, Peter

Izvornik
Journal of Personalized Medicine (2075-4426) 11 (2021), 6; 495-495

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
primary biliary cholangitis ; ursodeoxycholic acid ; prognostic factors ; treatment response ; liver decompensation

Sažetak
Objective: To identify pretreatment laboratory parameters associated with treatment response and to describe the relationship between treatment response and liver decompensation in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Methods: We defined treatment response as both ALP ≤ 1.67 × ULN and total bilirubin ≤ 2 × ULN. Multiple logistic regression analyses were performed to adjust for confounding effects of sociodemographic variables. Results: Pretreatment total bilirubin ((TB) ; OR = 0.3388, 95%CI = 0.1671–0.6077), ALT (OR = 0.5306, 95%CI = 0.3830–0.7080), AST (OR = 0.4065, 95%CI = 0.2690–0.5834), ALP (OR = 0.3440, 95%CI = 0.2356– 0.4723), total cholesterol ((TC) ; OR = 0.7730, 95%CI = 0.6242–0.9271), APRI (OR = 0.3375, 95%CI = 0.1833–0.5774), as well as pretreatment albumin (OR = 1.1612, 95%CI = 1.0706–1.2688) and ALT/ALP (OR = 2.4596, 95%CI = 1.2095–5.5472) were associated with treatment response after six months of treatment. Pretreatment TB (OR = 0.2777, 95%CI = 0.1288–0.5228), ALT (OR = 0.5968, 95%CI = 0.4354–0.7963), AST (OR = 0.4161, 95%CI = 0.2736– 0.6076), ALP (OR = 0.4676, 95%CI = 0.3487–0.6048), APRI (OR = 0.2838, 95%CI = 0.1433–0.5141), as well as pretreatment albumin (OR = 1.2359, 95%CI = 1.1257–1.3714) and platelet count (OR = 1.0056, 95%CI = 1.0011–1.0103) were associated with treatment response after 12 months of treatment. Treatment response after 6 months of UDCA therapy is significantly associated with treatment response after 12 months of UDCA therapy (OR = 25.2976, 95% CI = 10.5881–68.4917). Treatment responses after 6 and 12 months of UDCA therapy decrease the risk of an episode of liver decompensation in PBC patients (OR = 12.1156, 95%CI = 3.7192–54.4826 and OR = 21.6000, 95%CI = 6.6319–97.3840, respectively). Conclusions: There are several pretreatment laboratory parameters associated with treatment response in patients with primary biliary cholangitis. Treatment response after six months is significantly associated with treatment response after 12 months of ursodeoxycholic acid (UDCA) therapy. Treatment responses after 6 and 12 months of UDCA decrease the risk of an episode of liver decompensation.

Izvorni jezik
Engleski



POVEZANOST RADA


Poveznice na cjeloviti tekst rada:

doi www.mdpi.com pubmed.ncbi.nlm.nih.gov

Citiraj ovu publikaciju:

Gazda, Jakub; Drazilova, Sylvia; Janicko, Martin; Grgurevic, Ivica; Filipec Kanizaj, Tajana; Koller, Tomas; Bodorovska, Beatrica; Bozin, Tonci; Mijic, Maja; Rob, Zrinka et al.
Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients // Journal of Personalized Medicine, 11 (2021), 6; 495-495 doi:10.3390/jpm11060495 (međunarodna recenzija, članak, znanstveni)
Gazda, J., Drazilova, S., Janicko, M., Grgurevic, I., Filipec Kanizaj, T., Koller, T., Bodorovska, B., Bozin, T., Mijic, M. & Rob, Z. (2021) Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients. Journal of Personalized Medicine, 11 (6), 495-495 doi:10.3390/jpm11060495.
@article{article, year = {2021}, pages = {495-495}, DOI = {10.3390/jpm11060495}, keywords = {primary biliary cholangitis, ursodeoxycholic acid, prognostic factors, treatment response, liver decompensation}, journal = {Journal of Personalized Medicine}, doi = {10.3390/jpm11060495}, volume = {11}, number = {6}, issn = {2075-4426}, title = {Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients}, keyword = {primary biliary cholangitis, ursodeoxycholic acid, prognostic factors, treatment response, liver decompensation} }
@article{article, year = {2021}, pages = {495-495}, DOI = {10.3390/jpm11060495}, keywords = {primary biliary cholangitis, ursodeoxycholic acid, prognostic factors, treatment response, liver decompensation}, journal = {Journal of Personalized Medicine}, doi = {10.3390/jpm11060495}, volume = {11}, number = {6}, issn = {2075-4426}, title = {Prognostic Factors in Primary Biliary Cholangitis: A Retrospective Study of Joint Slovak and Croatian Cohort of 249 Patients}, keyword = {primary biliary cholangitis, ursodeoxycholic acid, prognostic factors, treatment response, liver decompensation} }

Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font